Revolution Medicines RVMD
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 35.36 | 112.81 | -1.13 | -240,760 | -213 | |
| 2024Q4 | 43.74 | 110.75 | -1.13 | -216,310 | -195 | |
| 2024Q3 | 45.35 | 112.43 | -0.94 | -175,712 | -156 | |
| 2024Q2 | 38.81 | 117.57 | -0.81 | -156,643 | -133 | |
| 2024Q1 | 32.23 | 121.43 | -0.70 | -140,859 | -116 | |
| 2023Q4 | 28.68 | 111.87 | -1.21 | -179,983 | -162 | |
| 2023Q3 | 27.68 | 109.75 | -1.00 | -123,248 | -108 | |
| 2023Q2 | 26.75 | 110.68 | -0.93 | -108,797 | -98 | |
| 2023Q1 | 21.66 | 110.37 | -0.72 | -75,157 | -68 | |
| 2022Q4 | 23.82 | 108.97 | -0.61 | -61,707 | -57 | |
| 2022Q3 | 19.72 | 103.95 | -0.87 | -76,533 | -73 | |
| 2022Q2 | 19.49 | 101.42 | -0.82 | -62,090 | -61 | |
| 2022Q1 | 25.51 | 100.52 | -0.78 | -57,949 | -58 | |
| 2021Q4 | 25.17 | 100.45 | -0.72 | -52,913 | -53 | |
| 2021Q3 | 27.51 | 100.42 | -0.72 | -53,163 | -53 | |
| 2021Q2 | 31.74 | 100.53 | -0.60 | -44,535 | -44 | |
| 2021Q1 | 45.88 | 100.63 | -0.53 | -37,397 | -37 | |
| 2020Q4 | 39.59 | 100.74 | -0.52 | -34,080 | -34 | |
| 2020Q3 | 34.80 | 101.28 | -0.38 | -27,551 | -27 | |
| 2020Q2 | 31.57 | 102.68 | -0.37 | -27,984 | -27 |